Windtree Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2018 | — | $-28.1M | $1.9M |
| Jun 2018 | — | $-28.4M | $638.0K |
| Sep 2018 | — | $-31.3M | $640.0K |
| Dec 2018 | — | $68.1M | $11.2M |
| Mar 2019 | — | $63.0M | $2.1M |
| Jun 2019 | — | $58.3M | $6.1M |
| Sep 2019 | — | $53.1M | $4.4M |
| Dec 2019 | — | $74.9M | $22.6M |
| Mar 2020 | — | $70.1M | $16.8M |
| Jun 2020 | — | $83.5M | $31.5M |
| Sep 2020 | — | $75.7M | $22.4M |
| Dec 2020 | — | $69.6M | $16.9M |
| Mar 2021 | — | $91.5M | $38.5M |
| Jun 2021 | — | $56.8M | $30.0M |
| Sep 2021 | — | $50.2M | $24.5M |
| Dec 2021 | — | $41.9M | $22.3M |
| Mar 2022 | — | $34.7M | $15.5M |
| Jun 2022 | — | $19.2M | $11.4M |
| Sep 2022 | — | $17.4M | $8.4M |
| Dec 2022 | — | $10.0M | $6.2M |
| Mar 2023 | — | $7.0M | $4.2M |
| Jun 2023 | — | $11.6M | $11.5M |
| Sep 2023 | — | $7.5M | $7.4M |
| Dec 2023 | — | $3.4M | $4.3M |
| Mar 2024 | — | $15.4M | $2.5M |
| Jun 2024 | — | $3.5M | $1.8M |
| Sep 2024 | — | $4.4M | $2.3M |
| Dec 2024 | — | $10.0M | $1.8M |
| Mar 2025 | — | $10.3M | $1.2M |
| Jun 2025 | — | $3.6M | $301.0K |
| Sep 2025 | — | $-11.6M | $204.0K |